Dipeptidyl peptidase-4 inhibitors reduce the incidence of first cardiovascular events in Japanese diabetic patients
ConclusionsOur findings have demonstrated that the use of DPP-4 inhibitors may be associated with a reduced incidence of first cardiovascular events in Japanese diabetic patients. The results require confirmation in randomized controlled trials.
Source: Heart and Vessels - Category: Cardiology Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Cholesterol | Diabetes | Endocrinology | Heart | Heart Failure | Hypertension | Insulin | Japan Health | Peripheral Vascular Disease (PVD) | Statin Therapy | Study